CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI)

Clinical trial NCT04331808 · COMPLETED

Trial details

NCT number: NCT04331808
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Corona Virus Infection

Start date: 2020-03-30
Primary completion: 2020-05-04
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.